Centellase has a new strategic visual and a new claim: “Ci prendiamo cura della tua bellezza” (We take care of your beauty).

SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022. 

SIT Group is pleased to announce the acquisition of Potasion brand from Sanofi, as a result of the agreement signed on November 8, 2022. 

SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022. 

The new Trofodermin TV spot is now on air.

Laboratorio Farmaceutico SIT is pleased to announce the release of the new Coryfin C senza zuccheri Miele e Zenzero.

SIT Group is pleased to announce the acquisition of LOPRESSOR, ICAZ and MIOREL from Daiichi Sankyo France, effective from 30th June 2020.

Trofodermin Spray has been on the market again since April 2020.

Laboratorio Farmaceutico SIT strengthens the relationship between Company and Doctor, with the implementation of its own network of medical representatives.

The new campaign of Coryfin is now on air.

The advertising campaign of Rino Calyptol returns live in December.

#sostenGO is an initiative to support female entrepreneurship, promoted by SIT Group since 2017

The advertising campaign of Rino Calyptol will be live in April.

The Ambient Marketing Fomentil has begun in Turin, Milan e Pavia.

The European Business magazine interviewed Lamberto Pedrotti, Managing Director of SIT Group.